DEF 14A Filing

Company

ORAMED PHARMACEUTICALS INC.

Filed

January 31, 2011

Period of Report

February 24, 2011

Accession Number

0001144204-11-004824

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →